
Investigate Shortness of Breath: Here's How
'All new episodes of shortness of breath should be evaluated in real time by a clinician, ideally in person,' said Panagis Galiatsatos, MD, MHS, pulmonologist and associate professor, Division of Pulmonary and Critical Care Medicine at Johns Hopkins School of Medicine in Baltimore.
But if the patient has a diagnosed condition, a phone or virtual discussion could be enough. 'The only time I can see foregoing an immediate clinic visit is if a known cardiopulmonary diagnosis exists,' Galiatsatos said.
For example, if you already know the patient has a pulmonary or cardiac condition and their dyspnea (shortness of breath) is similar to prior episodes of breathlessness, then an in-office appointment may not necessarily be needed, he said. Those could be managed by both an action plan that has already been discussed at prior visits.
A Red Flag During Office Visits
What if a patient is already in the office for another reason and casually mentions episodes of shortness of breath, how should the primary doctor proceed?
Panagis Galiatsatos, MD, MHS
Even if dyspnea is mentioned casually, it warrants a thorough history and focused physical exam, especially if this is new or worsening. This could be an early sign of a more serious problem, said Lijo Illipparambil, MD, pulmonologist and assistant professor of Clinical Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University in Philadelphia.
When discussing such symptoms, Illipparambil recommends these questions:
When do episodes occur — during exertion vs rest?
How long have these symptoms been occurring?
Are there other symptoms, like fatigue, chest tightness, wheezing, cough, or swelling?
How limiting are the symptoms? Is the patient able to climb stairs, and if so, how many? Is walking across a room or doing daily chores causing them to be dyspneic?
How to Be a Frontline Partner?
Primary care doctors are essential in identifying early signs of cardiopulmonary disease.
'Generally, they are the first physicians who meet the patients and do most of the work-up initially. They coordinate care, especially with specialists, provide lifestyle counseling, and monitor chronic conditions like COPD [chronic obstructive pulmonary disease], asthma, and congestive heart failure,' Illipparambil said.
Lijo Illipparambil, MD
In many ways, they are the real central component for care of patients with dyspnea, he affirmed. 'They also have the advantage of longitudinal relationships, allowing them to notice changes over time and engage in shared decision-making to create sustainable health strategies and earlier intervention if needed,' Illipparambil said.
Assessment Protocol
Usually, a thorough physical exam, including checking vital signs, especially oxygen saturation and heart rate, is next, Illipparambil said. And additional testing should be considered including chest x-ray, EKG, and laboratory work-up, as well as referral to specialists if warranted.
Red flags that warrant further testing include:
Dyspnea at rest is always a reason for further testing, he said. 'It is not normal to be short of breath at rest; it is most often a sign of significant impending decompensation. Additionally, Illipparambil said, worsening shortness of breath over days/weeks can demonstrate a progressive process. Difficulty walking short distances or performing basic activities (eg, walking in the supermarket, pushing a stroller), especially as a change from their baseline, can be a sign of an active problem.
Orthopnea or paroxysmal nocturnal dyspnea are signs of heart failure that need further investigation.
Unilateral leg swelling should always have a differential that includes deep venous thrombosis and possible pulmonary embolism if present when a patient is short of breath, he said.
Expert Assessments and Symptoms
Consider the shortness-of-breath assessments below, according to Galiatsatos:
Airway diseases. COPD or asthma are examples. 'I would recognize due to inability to walk incline or when holding groceries — not walking through the grocery store, but once their arms are engaged, their breathlessness is noticeable,' he explained.
Cardiac rhythm issues (especially low heart rates). Most people notice this breathlessness even within a few dozen feet or so of walking on flat surface, he cited.
Pulmonary embolism (lung blood clot). This is more acute in occurrence, and patients often describe a heaviness and uncomfortableness in their chest. 'This is often accompanied by something that provoked the blood clot, long hours of sitting say from a long flight, or a trauma to the legs,' Galiatsatos continued.
Heart failure. The key symptom here is the inability to lay down flat, he asserted. Patients may note having to sleep with several pillows, prompting their head and upper torso to be more and more vertical or abandoning sleeping in a bed and sleeping in a recliner, he also explained.
Lifestyle Strategies
The key is to be empathetic, collaborative, and goal oriented.
'This is indeed a delicate yet vital conversation,' Illipparambil said. There are several reasons for shortness of breath and approaching patients this way can help with patient openness and discussion. One thing that helps is the use of motivational interviewing techniques. For instance, he recommends asking permission to discuss weight, tobacco use, or other lifestyle habits that may be affecting shortness of breath can help establish a partnering role in these goals.
Another way to approach, he continued, is focusing on functions such as walking without getting winded and changing habits toward a healthy lifestyle rather than just the number on the scale.
'Additionally, offering resources and referrals for nutrition, sleep study, physical therapy, etc., can go a long way. Medications, of course, can help, especially inhalers in COPD and asthma patients. Antihypertensives and other medications that help modify heart disease, and goal-directed medical therapy have been shown to improve symptoms in patients with heart failure,' Illipparambil also said.
How Does Obesity Intersect With Shortness of Breath?
Obesity is often linked to cardiopulmonary deconditioning, according to Trishul Siddharthan, MD, pulmonologist and associate professor of the Department of Medicine with the University of Miami Miller School of Medicine and the UHealth — University of Miami Health System, both in Miami.
'Extra weight is a significant cause of shortness of breath in the general population and interacts with respiratory diseases like asthma to worsen symptoms,' Siddharthan outlined.
Lifestyle changes and other strategies to cope are a shared decision, he said. 'I ensure I address the underlying medical condition while addressing enablers and barriers to weight loss.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
purelyIV Launches Niagen® IV Therapy - A Breakthrough in NAD+ Cellular Wellness
Metro Detroit's leading mobile IV therapy provider introduces pharmaceutical-grade Niagen® infusions, offering a faster, more efficient, and more comfortable way to boost NAD+ levels at home. ROCHESTER HILLS, Mich., Aug. 1, 2025 /PRNewswire/ -- purelyIV, Metro Detroit's leading mobile IV therapy provider, is proud to announce the launch of Niagen® IV Therapy, a groundbreaking new service designed to efficiently boost NAD+ levels. This innovative treatment uses pharmaceutical-grade nicotinamide riboside chloride (NR) to deliver a faster, more comfortable NAD+ replenishment experience compared to traditional NAD+ IV infusions. Niagen® IV Therapy offers clients a cutting-edge approach to cellular health and wellness. Clinical studies show that Niagen® infusions raise whole-blood NAD+ levels 20% higher than standard NAD+ IV treatments and achieve peak levels within just three hours—while requiring 75% less infusion time. Treatments are typically completed in 30–45 minutes, allowing for a more convenient experience with fewer side effects. "Niagen® IV Therapy represents the next evolution of NAD+ boosting wellness," said Erin Boumansour, co-founder and lead practitioner at purelyIV. "We are excited to bring this advanced therapy to Metro Detroit, offering our clients an efficient and scientifically supported option to enhance energy, support cognitive health, and promote healthy aging—all delivered in the comfort of their home or office." purelyIV's licensed nurses administer Niagen® IV infusions in 500mg and 1000mg doses with 500ml of fluids and electrolytes. Clients can also choose add-on options like NiagenH IV Push and Niagen® Shots for a quick, convenient boost during other IV treatments. With its mobile, in-home service model and commitment to clinical excellence, purelyIV continues to lead the way in providing premium IV therapy solutions designed to meet the unique wellness goals of each client. To learn more about Niagen® IV Therapy or to schedule an appointment, visit Contact:Michael Boumansour***@ Photo(s): Press release distributed by PRLog View original content: SOURCE purelyIV Sign in to access your portfolio
Yahoo
17 minutes ago
- Yahoo
Why Moderna (MRNA) Stock Is Trading Lower Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper end of its 2025 revenue forecast, citing a delay in vaccine shipments. The company pointed to a delay in vaccine deliveries to the United Kingdom, which it pushed into the first quarter of 2026. This news overshadowed second-quarter results that beat Wall Street expectations. For the quarter, Moderna's revenue dropped about 41% from the previous year to $142 million, driven by lower sales of its COVID-19 vaccine. Despite the revenue decline, the company successfully narrowed its net loss as its cost-cutting measures took effect. Adding to the pressure, Moderna also announced plans to reduce its workforce by 10% and confirmed a delay in the U.S. approval for its combined COVID-flu vaccine until 2026. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Moderna? Access our full analysis report here, it's free. What Is The Market Telling Us Moderna's shares are extremely volatile and have had 53 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 4.9% on the news that industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending shockwaves across the health insurance sector. The core of the issue stems from an 'unprecedented medical cost trend environment,' particularly within the Medicare Advantage market, which are privately run versions of the federal health insurance program. UnitedHealth, the largest provider in this space, now expects these costs to rise by 7.5% in 2025, a significant jump from its earlier 5% projection, with the potential to accelerate to almost 10% in 2026. In response, the insurer announced it will drop plans covering over 600,000 people. The company's lowered earnings forecast has raised investor concerns that these surging costs and utilization rates are an industry-wide problem, impacting the profitability of other carriers as well. Moderna is down 34.6% since the beginning of the year, and at $27.47 per share, it is trading 70.8% below its 52-week high of $94.17 from July 2024. Investors who bought $1,000 worth of Moderna's shares 5 years ago would now be looking at an investment worth $352.27. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. 登入存取你的投資組合
Yahoo
17 minutes ago
- Yahoo
Freeze dried fruit sold at Sam's Club recalled due to listeria
Doehler Dry Ingredient Solutions, LLC is recalling boxes of Member's Mark freeze dried fruit due to potential listeria contamination, which can lead to serious illness. In an alert Friday, the U.S. Food and Drug Administration said the company discovered the problem affecting some 15-count boxes of "Member's Mark Freeze Dried Fruit Variety Pack" after internal product testing. So far, no illnesses have been reported. The recalled boxes are marked with UPC 1 93968 50900 2 and included varied lot codes and use-by dates, which can be found listed on the FDA's website. The product was distributed between July 1 and July 25, 2025, and sold in Sam's Club retail stores in 42 states, which are listed below. Officials are urging people not to eat the product. Consumers should discard it and visit any Sam's Club for a full refund, the FDA says. Listeria infections are caused by eating food contaminated with a bacteria called Listeria monocytogenes. Symptoms can include high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, the FDA said. The Centers for Disease Control and Prevention warns that people may also experience a stiff neck and flu-like symptoms, such as muscle aches and fatigue. Some people are at higher risk of severe cases and even death, including those who are pregnant, newborns, adults 65 or older, and those with weakened immune systems. Here is the list states where the products were sold: AlabamaArizonaCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasLouisianaMarylandMaineMichiganMinnesotaMissouriMississippiMontanaNorth CarolinaNorth DakotaNebraskaNew HampshireNew JerseyNew MexicoNevadaNew YorkOhioOklahomaPennsylvaniaSouth CarolinaSouth DakotaTennesseeTexasUtahVirginiaWisconsinWest VirginiaWyoming Consumers with questions may contact the company's customer service department at 1-770-387-0451, Monday through Friday, from 8 a.m. to 5 p.m. ET. Arkansas officials reveal new details about Devil's Den murders of husband and wife Diamond Dallas Page on Hulk Hogan's wrestling legacy Judge delays TPS program termination for migrants from Honduras, Nepal and Nicaragua Solve the daily Crossword